Longitudinal Brain size Measurements in App/ps1 Transgenic Mice

There appear to be species differences among the effects of gene mutations related to familial Alzheimer's disease on the brain during aging. To gain a better understanding of the effects of the Swedish mutation of amyloid precursor protein and the mutant form of human presenilin 1 on mice, commercially available mice from Jackson Laboratory were studied. Three dimensional T2*-weighted imaging was used to monitor the size of brains of APP/PS1 mice monthly, from 6 to 13 months of age. No significant difference was measured in the size of the medial-lateral width, dorsal-ventral height, rostral-caudal length or the volume of the APPSwe/ PS1 mouse brain. Faster and higher-resolution imaging methods are needed to accurately determine if small volume or shape changes occur in mouse brains with age or gene mutations.

[1]  J. Sethian,et al.  Fronts propagating with curvature-dependent speed: algorithms based on Hamilton-Jacobi formulations , 1988 .

[2]  Alert E. Moyer Physics in Canada. , 1991 .

[3]  G A Johnson,et al.  Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Townsend,et al.  Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. , 2000, Radiology.

[5]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[6]  G. Bartzokis,et al.  Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[7]  Marc Dhenain,et al.  Senile plaques do not induce susceptibility effects in T 2*‐weighted MR microscopic images , 2002, NMR in biomedicine.

[8]  Thomas Wisniewski,et al.  Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.

[9]  Thomas Wisniewski,et al.  Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.

[10]  Kiralee M. Hayashi,et al.  Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[11]  Xin Yu,et al.  Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. , 2003, The American journal of psychiatry.

[12]  Michael Garwood,et al.  In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent , 2004, Magnetic resonance in medicine.

[13]  Demetri Terzopoulos,et al.  Snakes: Active contour models , 2004, International Journal of Computer Vision.

[14]  Susumu Mori,et al.  Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging , 2004, Magnetic resonance in medicine.

[15]  Thomas Wisniewski,et al.  Magnetic Resonance in Medicine 51:794–798 (2004) MRI Assessment of Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease , 2022 .

[16]  Chunming Li,et al.  Level set evolution without re-initialization: a new variational formulation , 2005, 2005 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (CVPR'05).

[17]  A Van der Linden,et al.  Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease , 2005, Magnetic resonance in medicine.

[18]  Clifford R Jack,et al.  Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Eric M. Reiman,et al.  Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice , 2006, Brain Research.

[20]  Marc Dhenain,et al.  Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease , 2006, Neurobiology of Disease.

[21]  J. Thiessen,et al.  MAGNETIC RESONANCE IMAGING AND BEHAVIOURAL TEST COMPARISONS IN A MOUSE MODEL OF ALZHEIMER'S DISEASE , 2007 .

[22]  Clifford R Jack,et al.  Magnetic Resonance Imaging of Alzheimer's Pathology in the Brains of Living Transgenic Mice: A New Tool in Alzheimer's Disease Research , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[23]  Ulf Norinder,et al.  Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice , 2008, Neurobiology of Aging.

[24]  Nick C Fox,et al.  Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging , 2008, Neurobiology of Aging.

[25]  Michael I. Miller,et al.  Parallel Transport in Diffeomorphisms Distinguishes the Time-dependent Pattern of Hippocampal Surface Deformation Due to Healthy Aging and the Dementia of the Alzheimer's Type , 2007 .

[26]  C. Jack,et al.  MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment , 2008, Neurology.

[27]  Anqi Qiu,et al.  Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease , 2009, NeuroImage.

[28]  Yutong Liu,et al.  A semi-automatic image segmentation method for extraction of brain volume from in vivo mouse head magnetic resonance imaging using Constraint Level Sets , 2009, Journal of Neuroscience Methods.

[29]  Nick C Fox,et al.  Hippocampal atrophy rates in Alzheimer disease , 2009, Neurology.

[30]  Nick C. Fox,et al.  A meta-analysis of hippocampal atrophy rates in Alzheimer's disease , 2009, Neurobiology of Aging.

[31]  Carey E. Priebe,et al.  Collaborative computational anatomy: An MRI morphometry study of the human brain via diffeomorphic metric mapping , 2009, Human Brain Mapping.

[32]  Daniel Rueckert,et al.  Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP×PS1 mice using MRI , 2009, Brain Research.

[33]  J. Thiessen,et al.  Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer’s disease , 2010, Brain Structure and Function.